COVID-19 Infection in Patients With Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study

Detalles Bibliográficos
Autores principales: Niemann, Carsten U., Awan, Farrukh T., Fogliatto, Laura, Nikitin, Eugene, Samoilova, Olga, Habib, Adel, Foroutanpour, Kayhan, Kuptsova-Clarkson, Nataliya, Opat, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509175/
https://www.ncbi.nlm.nih.gov/pubmed/36168519
http://dx.doi.org/10.1097/HS9.0000000000000780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509175/
https://www.ncbi.nlm.nih.gov/pubmed/36168519
http://dx.doi.org/10.1097/HS9.0000000000000780

Ejemplares similares